Sanicka, Inc

MicroBplex, Inc., based in Atlanta, GA, is pioneering a new class of in vitro diagnostic products aimed at the early detection of infectious diseases. Their innovative technology allows for the assessment of therapeutic effectiveness and immune protection without the need for pathogen isolation, addressing significant gaps in current diagnostic methods. By focusing on the detection of the patient's earliest cellular immune response to infectious pathogens, MicroBplex offers solutions that minimize the risks and limitations associated with traditional diagnostic approaches. Their products are particularly impactful for patients suffering from Lyme disease and Clostridium difficile infections, providing critical support in the management of these conditions. Generated from the website

Georgia Life Sciences serves as the leading advocate for the state's dynamic and diverse life sciences sector, promoting policy development, community programs, and industry initiatives to support research and product development among its member organizations. By fostering networking opportunities and providing resources for workforce development, economic growth, and entrepreneurship, Georgia Life Sciences aims to advance life sciences innovation at all levels of government. Membership in Georgia Life Sciences connects individuals and organizations to a vibrant community dedicated to improving health and advancing the bioscience industry. The organization also offers a range of supportive programs, including cost-saving initiatives, educational resources, and professional development opportunities for educators and emerging leaders in the life sciences field. Generated from the website

Micron Biomedical, Inc., based in Atlanta, GA, is pioneering the future of healthcare through innovative needle-free therapeutics and vaccine delivery systems. Their proprietary dissolvable microarray technology enables painless self-administration of medicines, making life-saving pharmaceuticals accessible to populations across various settings, including homes and remote locations. The company is addressing significant challenges within traditional vaccine and drug administration by reducing the need for cold chain logistics, allowing non-medical personnel to safely administer treatments, and aiming to alleviate vaccine hesitancy. With substantial grant support and partnerships, Micron Biomedical is committed to enhancing global vaccine access and improving patient compliance through its cutting-edge solutions. Generated from the website